SILVERARC CAPITAL MANAGEMENT, LLC TRVI — TREVI THERAPEUTICS INC

Ownership history in SILVERARC CAPITAL MANAGEMENT, LLC  ·  15 quarters on record

AI Ownership Summary

SILVERARC CAPITAL MANAGEMENT, LLC reported TREVI THERAPEUTICS INC (TRVI) in 15 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.94% in 2025 Q4. The latest visible filing shows TRVI at 0.62% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this TRVI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SILVERARC CAPITAL MANAGEMENT, LLC's position in TREVI THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

TRVI was reported at 0.62% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.94% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

TRVI stock page SILVERARC CAPITAL MANAGEMENT, LLC fund profile SILVERARC CAPITAL MANAGEMENT, LLC full holdings
How SILVERARC CAPITAL MANAGEMENT, LLC held TRVI — position size vs. price
% of Fund (quarterly)    TRVI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 511,127 -30,113 -5.6% 0.62% $6.1M 2026-05-14 $15.08
2025 Q4 REDUCED 8.1% -4.7% ✅ 541,240 -47,549 -8.1% 0.94% $6.8M 2026-02-12 $10.94
2025 Q3 ADDED — — — 588,789 +49,202 +9.1% 0.73% $5.4M 2025-11-12 $11.85
2025 Q2 ADDED — — — 539,587 +9,587 +1.8% 0.54% $3.0M 2025-08-14 $7.49
2025 Q1 REDUCED 27.8% -13.0% ✅ 530,000 -204,234 -27.8% 0.68% $3.3M 2025-05-14 $6.19
2024 Q4 ADDED — — — 734,234 +251,659 +52.1% 0.66% $3.0M 2025-02-14 $4.07
2024 Q3 REDUCED 42.8% +22.8% ❌ 482,575 -361,660 -42.8% 0.36% $1.6M 2024-11-14 $2.86
2024 Q2 UNCHANGED — — — 844,235 — 0% 0.59% $2.5M 2024-08-14 $2.61
2024 Q1 REDUCED — — — 844,235 -19,648 -2.3% 0.81% $2.9M 2024-05-15 $2.77
2023 Q4 REDUCED 6.9% +150.8% ❌ 863,883 -63,532 -6.9% 0.34% $1.2M 2024-02-14 $2.12
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding TRVI

As of 2026 Q1 — sorted by position size

NEA Management Company, LLC 3Y 7Y 8.97% ACORN CAPITAL ADVISORS, LLC 7.27% Pivotal bioVenture Partners Investment Advisor LLC 3Y 6.63% Vivo Capital, LLC 3Y 7Y 5.07% Artia Global Partners LP 3Y 4.81% KVP Capital Advisors, LP 3.69% Frazier Life Sciences Management, L.P. 3Y 3.05% MPM BioImpact LLC 3Y 3.04% SUPERSTRING CAPITAL MANAGEMENT LP 2.14% Octagon Capital Advisors LP 3Y 1.96%

FAQ About SILVERARC CAPITAL MANAGEMENT, LLC and TRVI

These are the practical questions this page is built to answer before you even open the full history table.

How long has SILVERARC CAPITAL MANAGEMENT, LLC reported owning TRVI?

SILVERARC CAPITAL MANAGEMENT, LLC reported TRVI across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported TRVI position in SILVERARC CAPITAL MANAGEMENT, LLC's portfolio?

The largest reported portfolio weight for TRVI was 0.94% in 2025 Q4.

What is the latest reported TRVI position on this page?

The most recent filing on this page is 2026 Q1, when SILVERARC CAPITAL MANAGEMENT, LLC reported 511,127 shares, equal to 0.62% of portfolio, with an estimated market value of $6.1M.

What does the chart on this TRVI ownership page compare?

The chart compares SILVERARC CAPITAL MANAGEMENT, LLC's quarterly TRVI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SILVERARC CAPITAL MANAGEMENT, LLC time their TRVI position?

Based on 13F filing dates vs. subsequent TRVI price moves, SILVERARC CAPITAL MANAGEMENT, LLC correctly timed 5 out of 12 reported position changes (42%). The annualised alpha on TRVI relative to SPY over the holding period was +46.0%.

← Back to SILVERARC CAPITAL MANAGEMENT, LLC Holdings